Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype

Individualizing adjuvant chemotherapy is important in patients with advanced colorectal cancers (CRCs), and the ability to identify molecular subtypes predictive of good prognosis for stage III CRCs after adjuvant chemotherapy could be highly beneficial. We performed microarray-based gene expression...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Kwon, Yujin, Park, Minhee, Jang, Mi, Yun, Seongju, Kim, Won Kyu, Kim, Sora, Paik, Soonmyung, Lee, Hyun Jung, Hong, Sungpil, Kim, Tae Il, Min, Byungsoh, Kim, Hoguen
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5503619/
https://ncbi.nlm.nih.gov/pubmed/28455965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados